Ftse Mib
34.396,13
0,24%
DAX
20.242,57
-0,05%
S&P 500
6.007,05
-0,72%
NASDAQ
20.023,11
-0,43%
Bitcoin
103.549,96
-2,45%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Solid Biosciences Inc (SLDB) Solid Biosciences Inc (SLDB) Notizie

SLDB

Solid Biosciences (SLDB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SLDB
DataOraFonteTitoloSimboloCompagnia
04/12/202423:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLDBSolid Biosciences Inc
04/12/202414:00GlobeNewswire Inc.Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene TherapiesNASDAQ:SLDBSolid Biosciences Inc
03/12/202414:00GlobeNewswire Inc.Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLDBSolid Biosciences Inc
26/11/202414:00GlobeNewswire Inc.Solid Biosciences to Participate at Upcoming Investor ConferencesNASDAQ:SLDBSolid Biosciences Inc
14/11/202418:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SLDBSolid Biosciences Inc
14/11/202414:00GlobeNewswire Inc.Solid Biosciences to Present at the Jefferies London Healthcare ConferenceNASDAQ:SLDBSolid Biosciences Inc
12/11/202422:58Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SLDBSolid Biosciences Inc
06/11/202422:05GlobeNewswire Inc.Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:SLDBSolid Biosciences Inc
06/11/202422:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLDBSolid Biosciences Inc
31/10/202413:00GlobeNewswire Inc.Solid Biosciences to Participate at the Truist Securities BioPharma SymposiumNASDAQ:SLDBSolid Biosciences Inc
23/09/202414:00GlobeNewswire Inc.Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines ConferenceNASDAQ:SLDBSolid Biosciences Inc
12/09/202414:00GlobeNewswire Inc.Solid Biosciences to Participate at the 2024 Cantor Global Healthcare ConferenceNASDAQ:SLDBSolid Biosciences Inc
13/08/202422:08GlobeNewswire Inc.Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:SLDBSolid Biosciences Inc
05/08/202414:00GlobeNewswire Inc.Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLDBSolid Biosciences Inc
01/07/202414:00GlobeNewswire Inc.Solid Biosciences Joins the Russell 3000® IndexNASDAQ:SLDBSolid Biosciences Inc
12/06/202402:43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SLDBSolid Biosciences Inc
11/06/202422:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLDBSolid Biosciences Inc
11/06/202422:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLDBSolid Biosciences Inc
20/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLDBSolid Biosciences Inc
15/05/202414:26Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:SLDBSolid Biosciences Inc
15/05/202413:52GlobeNewswire Inc.Solid Biosciences Provides First Quarter 2024 Business Update and Financial ResultsNASDAQ:SLDBSolid Biosciences Inc
07/05/202413:00GlobeNewswire Inc.Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:SLDBSolid Biosciences Inc
01/04/202413:45GlobeNewswire Inc.Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003NASDAQ:SLDBSolid Biosciences Inc
27/03/202412:00GlobeNewswire Inc.Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy SymposiumNASDAQ:SLDBSolid Biosciences Inc
13/03/202412:44GlobeNewswire Inc.Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial ResultsNASDAQ:SLDBSolid Biosciences Inc
07/03/202413:00GlobeNewswire Inc.Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHDNASDAQ:SLDBSolid Biosciences Inc
30/01/202422:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SLDBSolid Biosciences Inc
20/01/202401:23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SLDBSolid Biosciences Inc
16/01/202414:50Dow Jones NewsSolid Biosciences Gets Orphan Drug Designation for SGT-003NASDAQ:SLDBSolid Biosciences Inc
16/01/202414:00GlobeNewswire Inc.Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003NASDAQ:SLDBSolid Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SLDB

La tua Cronologia

EU
COIB
LS 1X Coinbase Tracker ETP
LSE
AZ55
Barrow Fnd.62 A
NYSE
SLB
Schlumberger
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network